Universal Health Services (UHS)

NYSE Health Care Health Care Facilities S&P 500
$195.50
-3.09 (-1.56%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$23.88
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 27, 2026Sep/2026$5.31$5.22-1.7%

Our record of UHS's reports since we began tracking; it grows each quarter.

Latest results, in brief

All UHS 8-K briefs →
Oct 27, 5:03 PM ET

Universal Health Services Q3 profit falls to $5.22 per share as revenue rises 5.3%

Mixed earnings 2.02

Universal Health Services reported third-quarter 2026 net income attributable to UHS of $308.7 million, or $5.22 per diluted share, down from $373.0 million, or $5.86 per diluted share, a year earlier. Net revenues rose 5.3% to $4.733 billion, and the company said a tentative settlement of the Cumberland Litigation drove a $26 million reserve increase, which shareholders should weigh against the higher revenue.

  • Q3 2026 net income attributable to UHS was $308.7 million, or $5.22 per diluted share, versus $373.0 million, or $5.86, in Q3 2025
  • Net revenues rose 5.3% to $4.733 billion from $4.495 billion
  • A $26 million pre-tax reserve increase tied to the tentative Cumberland settlement was partly offset by $47 million in favorable Medicaid supplemental payments
  • Repurchased 1.35 million shares for about $242.1 million in Q3; about $735.4 million remained under the authorization as of September 30, 2026
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$4.73B+5.3% $5.22-10.9% $308.68M6.5%
Jun 2026$4.64B+8.3% $5.98+10.1% $358.45M7.7%
Mar 2026$4.50B+9.6% $5.65+17.7% $348.68M7.8%
Dec 2025$4.49B+9.1% $7.03+42.3% $445.94M9.9%
Sep 2025$4.50B+13.4% $5.86+54.2% $372.96M8.3%
Jun 2025$4.28B+9.6% $5.43+27.5% $353.22M8.2%
Mar 2025$4.10B+6.7% $4.80+25.7% $316.68M7.7%
Dec 2024$4.11B+11.1% $4.94+57.3% $332.40M8.1%

From Universal Health Services's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$17.36B+9.7% $23.10+37.3%8.6%
FY2024$15.83B+10.8% $16.82+64.4%7.2%
FY2023$14.28B+6.6% $10.23+11.9%5.0%
FY2022$13.40B+6.0% $9.14-22.7%5.0%
FY2021$12.64B+9.4% $11.82+7.6%7.8%

Frequently asked questions

When is Universal Health Services's next earnings date?

Universal Health Services has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Universal Health Services earn last quarter?

For the quarter ended Sep 2026, Universal Health Services reported diluted EPS of $5.22 (-10.9% year over year) on revenue of $4.73B (+5.3%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.